Wealthspire Advisors (Maryland)’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,072
Closed -$29K 1364
2019
Q1
$29K Sell
1,072
-213
-17% -$7.14K ﹤0.01% 1124
2018
Q4
$42K Buy
1,285
+164
+15% +$6.59K ﹤0.01% 936
2018
Q3
$52K Buy
1,121
+68
+6% +$3.12K ﹤0.01% 952
2018
Q2
$46K Buy
1,053
+75
+8% +$3.59K ﹤0.01% 1005
2018
Q1
$54K Sell
978
-436
-31% -$23.9K 0.01% 948
2017
Q4
$76K Buy
1,414
+176
+14% +$8.3K 0.01% 827
2017
Q3
$53K Buy
1,238
+347
+39% +$16.5K 0.01% 957
2017
Q2
$54K Sell
891
-2,231
-71% -$132K 0.01% 925
2017
Q1
$217K Buy
3,122
+92
+3% +$6.39K 0.03% 366
2016
Q4
$202K Sell
3,030
-179
-6% -$11.6K 0.03% 364
2016
Q3
$213K Buy
3,209
+247
+8% +$16.9K 0.03% 364
2016
Q2
$215K Buy
2,962
+2,231
+305% +$153K 0.04% 345
2016
Q1
$47K Buy
731
+90
+14% +$5.97K 0.01% 718
2015
Q4
$46K Buy
+641
New +$47.4K 0.01% 739

Other funds holding MD

Wealthspire Advisors (Maryland)'s MD Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Pediatrix Medical (MD) in Q2 2019, closing a stake of 1,072 shares — an estimated $29K sold.

Wealthspire Advisors (Maryland) first reported a position in MD in Q4 2015 and held it in 14 quarters. The position peaked at $217K in Q1 2017. 247 funds tracked by Wall St. Rank hold MD as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Pediatrix Medical position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 1,072 Pediatrix Medical shares in Q2 2019, an estimated $29K.
  • Wealthspire Advisors (Maryland) first reported a position in Pediatrix Medical in Q4 2015 and held it in 14 quarters.
  • Wealthspire Advisors (Maryland)'s Pediatrix Medical position peaked at $217K in Q1 2017.
  • 247 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.